Mary Ann Liebert, Inc.

This Thanksgiving, we celebrated in style at Mary Ann Liebert, Inc.! Along with a festive luncheon, we held our first Top Chef competition, and the results were deliciously creative. 🏆🍂 We’re so thankful for our incredible team and wish you all a joyful and delicious Thanksgiving! 🦃🍁 #Thanksgiving2024 #TeamAppreciation #MaryAnnLiebertInc #TopChefChallenge

NEW PODCAST! Mini-PCNL vs Standard PCNL: Why are we still talking about this? In this episode we discuss the contemporary use of mini PCNL. The panelists including Dr. Gupta and Dr. Knoll explain what they are currently doing in their respective practices and discuss the future of Mini PCNL with the technological evolution in kidney stone disease surgery. LISTEN to this free podcast sponsored by Boston Scientific: https://hubs.li/Q02ZmRB_0

🚂🔍 Our company book club's latest pick was "Murder on the Orient Express" by Agatha Christie! This timeless classic took us on a suspenseful journey aboard a luxurious train, unraveling a mysterious murder case led by the brilliant detective Hercule Poirot. 🕵️♂️💼 We immersed ourselves in the intricate plot, fascinating characters, and unexpected twists that define this masterpiece of the mystery genre. #MurderOnTheOrientExpress #AgathaChristie #companybookclub #LiteraryMystery #LiebertLife

Submissions Now Open! We're excited to announce that Diabetes Technology and Obesity Medicine, an international peer-reviewed open access journal led by Editor-in-Chief Gitanjali Srivastava MD, FAAP, FACP, is now accepting submissions. Dedicated to advancing the management of diabetes and obesity, our mission is to equip healthcare professionals with cutting-edge insights into: - Emerging devices - Advanced pharmacological treatments - Innovative drug delivery systems - State-of-the-art software solutions, including AI-driven tools To celebrate our launch, we're waiving all Article Processing Charges (APCs) for submissions received by January 31, 2025. Don't miss this opportunity to showcase your research and contribute to a growing community of healthcare innovators! Submit your work today and help shape the future of diabetes and obesity care: https://lnkd.in/g_aHUNJV

🚀 DON'T MISS OUT! Harnessing AI to Revolutionize Cancer Screening In this December 3rd webinar, moderated by Sanjay Juneja, M.D. (VP Clinical AI Applications at Tempus Ai) our expert panelists (Douglas Flora, MD, LSSBB, FACCC, Sarah M. Dunlap, Ph.D., Robert Smith, Lecia Sequist, MD) will discuss and evaluate current AI applications in cancer screening, including success stories and ongoing challenges. Register now to join us for this free webinar sponsored by AstraZeneca: https://hubs.li/Q02XXkN60 #CancerScreening

The CEO Roundtable on Cancer is pleased to highlight our CEO Dr. Sean Khozin as a featured speaker at the upcoming virtual summit, The State of AI in Precision Oncology 2024. 🗓️ Date: Thursday, December 12, 2024 ⏰ Time: 11:00 AM - 3:15 PM EST 📍 Location: Virtual 💻 Registration: Free Hosted by AI in Precision Oncology, this summit brings together leading experts in oncology, artificial intelligence, and healthcare innovation to discuss how AI is advancing precision medicine and transforming cancer care. Dr. Khozin will participate in a fireside chat to discuss the state of AI in oncology, its role in personalized treatment approaches, and its potential to improve outcomes for patients worldwide. This summit is an opportunity for healthcare professionals, researchers, investors, and industry leaders to gain insights from some of the foremost voices in AI and oncology. Reserve your spot today: https://lnkd.in/eSctKaU7

We’re pleased to welcome Wai Hong (Kevin) Lo, PhD, as the new Editor-in-Chief of ASSAY and Drug Development Technologies. Dr. Lo brings over 20 years of expertise in drug discovery and translational science, along with a strong editorial background. He shared his vision for the journal: "I plan to introduce innovative approaches, such as enhancing online accessibility, incorporating visuals and lay summaries, and increasing social media engagement. These efforts will help us reach a broader audience, making our content more engaging and relevant to diverse scientific and industrial communities." We also extend our gratitude to Bruce Melancon, PhD, for his outstanding service as Editor-in-Chief. Explore the journal: https://hubs.li/Q02YXnQm0 #Leadership #DrugDevelopment #Biotechnology #ASSAYJournal

New eBook! Accessible Testing For All: A Syndemic Approach to Syphilis, HIV and HCV Screening This eBook from OraSure Technologies, a leading organization in infectious disease diagnostics, provides an overview of the rising STI syndemic as well as solutions, workflows, case studies, and insights to improve syphilis, HIV and HCV testing. DOWNLOAD: https://hubs.li/Q02Y7LzB0

📣 Join The OncDoc himself, Dr. Sanjay Juneja, M.D., at the second Annual State of AI in Precision Oncology Summit 2024! You won't want to miss Dr. Juneja's fireside chat about how AI relates to health care and everything related to oncology from imaging, pathology, and clinical utility as well as administrative. 📅 Save the Date: Thursday, December 12, 2024 🎟️ Register here: https://bit.ly/3YZ8NWH Don’t miss this chance to stay ahead in precision oncology. Let’s shape the future together! #PrecisionOncology #AIInMedicine #HealthcareInnovation #LiebertSummit2024

New eBook! From Platforms to Patients: Quality Targeted Temperature Management for Acute Care The articles included in this eBook provide thoughtful information to clinical care personnel and individuals administering TH and TTM for their respective patient populations. DOWNLOAD this free eBook sponsored by ZOLL Medical Corporation: https://hubs.li/Q02YBcKf0 #THER